Rhizopus Infection in a Preterm Infant: A Novel Use of Posaconazole.
PEDIATRIC INFECTIOUS DISEASE JOURNAL(2020)
Abstract
Posaconazole is a triazole antifungal with activity against Rhizopus, but data on its use and pharmacokinetics in preterm infants are scarce. In this case, a 24 4/7-week neonate's Rhizopus infection is successfully treated with debridement and combination antifungal therapy with amphotericin B, micafungin and enteral posaconazole. This is the first reported posaconazole use in a preterm neonate with Rhizopus.
MoreTranslated text
Key words
Mucor,mucormycosis,neonatal,posaconazole,Rhizopus
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined